Kearsey J - Search Results

1

Qualitative gene profiling: a novel tool in genomics and in pharmacogenomics that deciphers messenger RNA isoforms diversity.

Schweighoffer F, Ait-Ikhlef A, Resink AL, Brinkman B, Melle-Milovanovic D, Laurent-Puig P, Kearsey J, Bracco L. Schweighoffer F, et al. Among authors: kearsey j. Pharmacogenomics. 2000 May;1(2):187-97. doi: 10.1517/14622416.1.2.187. Pharmacogenomics. 2000. PMID: 11256590 Review.

2

The relevance of alternative RNA splicing to pharmacogenomics.

Bracco L, Kearsey J. Bracco L, et al. Among authors: kearsey j. Trends Biotechnol. 2003 Aug;21(8):346-53. doi: 10.1016/S0167-7799(03)00146-X. Trends Biotechnol. 2003. PMID: 12902171 Review.

3

A novel four transmembrane spanning protein, CLP24. A hypoxically regulated cell junction protein.

Kearsey J, Petit S, De Oliveira C, Schweighoffer F. Kearsey J, et al. Eur J Biochem. 2004 Jul;271(13):2584-92. doi: 10.1111/j.1432-1033.2004.04186.x. Eur J Biochem. 2004. PMID: 15206924 Free article.

4

Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.

De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F. De Coupade C, et al. Among authors: kearsey j. Biochem J. 2005 Sep 1;390(Pt 2):407-18. doi: 10.1042/BJ20050401. Biochem J. 2005. PMID: 15859953 Free PMC article.

5

Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell).

Meyer-Losic F, Quinonero J, Dubois V, Alluis B, Dechambre M, Michel M, Cailler F, Fernandez AM, Trouet A, Kearsey J. Meyer-Losic F, et al. Among authors: kearsey j. J Med Chem. 2006 Nov 16;49(23):6908-16. doi: 10.1021/jm0606591. J Med Chem. 2006. PMID: 17154520

6

DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies.

Meyer-Losic F, Nicolazzi C, Quinonero J, Ribes F, Michel M, Dubois V, de Coupade C, Boukaissi M, Chéné AS, Tranchant I, Arranz V, Zoubaa I, Fruchart JS, Ravel D, Kearsey J. Meyer-Losic F, et al. Among authors: kearsey j. Clin Cancer Res. 2008 Apr 1;14(7):2145-53. doi: 10.1158/1078-0432.CCR-07-4580. Clin Cancer Res. 2008. PMID: 18381956

7

Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin.

Ravel D, Dubois V, Quinonero J, Meyer-Losic F, Delord J, Rochaix P, Nicolazzi C, Ribes F, Mazerolles C, Assouly E, Vialatte K, Hor I, Kearsey J, Trouet A. Ravel D, et al. Among authors: kearsey j. Clin Cancer Res. 2008 Feb 15;14(4):1258-65. doi: 10.1158/1078-0432.CCR-07-1165. Clin Cancer Res. 2008. PMID: 18281561

8

Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1.

Kearsey JM, Coates PJ, Prescott AR, Warbrick E, Hall PA. Kearsey JM, et al. Oncogene. 1995 Nov 2;11(9):1675-83. Oncogene. 1995. PMID: 7478594

9

Characterisation of the interaction between PCNA and Gadd45.

Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E, Cox LS. Hall PA, et al. Among authors: kearsey jm. Oncogene. 1995 Jun 15;10(12):2427-33. Oncogene. 1995. PMID: 7784094

10

Does the p53 up-regulated Gadd45 protein have a role in excision repair?

Kearsey JM, Shivji MK, Hall PA, Wood RD. Kearsey JM, et al. Science. 1995 Nov 10;270(5238):1004-5; author reply 1005-6. Science. 1995. PMID: 7481777 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters